Literature DB >> 27720209

Decreasing prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus among blood isolates in Korean hospitals.

Yu Ri Kang1, Doo Ryeon Chung2, Jin Yang Baek1, So Hyun Kim1, Sun Young Cho3, Young Eun Ha4, Cheol-In Kang4, Kyong Ran Peck4, Nam Yong Lee5, Jae-Hoon Song6.   

Abstract

We investigated the prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) among methicillin-resistant S. aureus (MRSA) blood isolates collected from Korean hospitals. The hVISA prevalence in Korean hospitals has decreased during the past decade and the most significant decrease of hVISA prevalence was observed among the ST5 MRSA.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Genotype; Methicillin-resistant Staphylococcus aureus; Minimum inhibitory concentration; Vancomycin resistance

Mesh：

Year:  2016        PMID： 27720209     DOI： 10.1016/j.diagmicrobio.2016.09.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  2 in total

1.  Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.

Authors:  Aref Shariati; Masoud Dadashi; Majid Taati Moghadam; Alex van Belkum; Somayeh Yaslianifard; Davood Darban-Sarokhalil
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

2.  Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study.

Authors:  Yu Ri Kang; Si-Ho Kim; Doo Ryeon Chung; Jae-Hoon Ko; Kyungmin Huh; Sun Young Cho; Cheol-In Kang; Kyong Ran Peck
Journal:  Antimicrob Resist Infect Control       Date:  2022-08-05       Impact factor: 6.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.